Platinum Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-13,820
| Closed | -$1.18M | – | 101 |
|
|
2019
Q2 | $1.18M | Hold |
13,820
| – | – | 0.03% | 80 |
|
|
2019
Q1 | $1.23M | Hold |
13,820
| – | – | 0.03% | 81 |
|
|
2018
Q4 | $1.18M | Hold |
13,820
| – | – | 0.04% | 69 |
|
|
2018
Q3 | $1.34M | Hold |
13,820
| – | – | 0.04% | 64 |
|
|
2018
Q2 | $1.3M | Hold |
13,820
| – | – | 0.03% | 65 |
|
|
2018
Q1 | $1.12M | Hold |
13,820
| – | – | 0.03% | 69 |
|
|
2017
Q4 | $1.23M | Hold |
13,820
| – | – | 0.03% | 62 |
|
|
2017
Q3 | $1.29M | Hold |
13,820
| – | – | 0.03% | 60 |
|
|
2017
Q2 | $1.26M | Hold |
13,820
| – | – | 0.03% | 59 |
|
|
2017
Q1 | $1.21M | Hold |
13,820
| – | – | 0.03% | 60 |
|
|
2016
Q4 | $1.14M | Hold |
13,820
| – | – | 0.03% | 58 |
|
|
2016
Q3 | $1.28M | Sell |
13,820
-3,400
| -20% | -$314K | 0.03% | 63 |
|
|
2016
Q2 | $1.34M | Hold |
17,220
| – | – | 0.03% | 58 |
|
|
2016
Q1 | $1.42M | Hold |
17,220
| – | – | 0.03% | 60 |
|
|
2015
Q4 | $1.8M | Sell |
17,220
-4,000
| -19% | -$419K | 0.04% | 53 |
|
|
2015
Q3 | $2.23M | Hold |
21,220
| – | – | 0.06% | 46 |
|
|
2015
Q2 | $2.9M | Hold |
21,220
| – | – | 0.06% | 49 |
|
|
2015
Q1 | $2.64M | Sell |
21,220
-12,300
| -37% | -$1.53M | 0.05% | 59 |
|
|
2014
Q4 | $3.03M | Hold |
33,520
| – | – | 0.06% | 63 |
|
|
2014
Q3 | $2.42M | Buy |
33,520
+7,000
| +26% | +$505K | 0.05% | 60 |
|
|
2014
Q2 | $1.65M | Buy |
26,520
+18,000
| +211% | +$1.12M | 0.03% | 70 |
|
|
2014
Q1 | $581K | Hold |
8,520
| – | – | 0.01% | 87 |
|
|
2013
Q4 | $599K | Hold |
8,520
| – | – | 0.01% | 82 |
|
|
2013
Q3 | $614K | Hold |
8,520
| – | – | 0.01% | 78 |
|
|
2013
Q2 | $474K | Buy |
+8,520
| New | +$474K | 0.01% | 73 |
|